Lietuvos pirminių imunodeficitų draugija Imunas - financials and debts
Company age: 8 y. 5 mo.
Company finances
|
EUR
|
2018
From: 2018-04-11
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | - | - | - | 54 | 1,887 | 5,311 | 7,577 |
| Profit before tax | - | - | - | - | 0 | 0 | 0 | 0 |
| Net profit | - | - | - | - | 0 | 0 | 0 | 0 |
| Equity | 0 | 0 | 0 | 0 | 2,533 | 0 | 0 | 0 |
| Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 85 | 1,667 | 1,820 | 2,434 | 2,533 | 2,374 | 4,851 | 7,473 |
| Total assets | 85 | 1,667 | 1,820 | 2,434 | 2,533 | 2,374 | 4,851 | 7,473 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | - | - | - | +3394.4% | +181.5% | +42.7% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | 0.0% | 0.0% | 0.0% | 0.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | 0.0% | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | 0.0% | 0.0% | 0.0% | 0.0% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | 0.0% | 0.0% | 0.0% | 0.0% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | - | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Social security debts
The company had no debts to Sodra
VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Lietuvos pirminiu imunodeficitu draugija Imunas (code 304824659) is an Association operating in activities of other membership organisations n.e.c. In the latest financial year, 2025, the company generated revenue of EUR 7.6K, up from EUR 5.3K in 2024 and EUR 1.9K in 2023. This shows a clear two-year expansion in activity, with revenue growth of 42.7% year on year in 2025 and cumulative growth of 301.5% over two years. The balance sheet also strengthened over the period, with total assets rising from EUR 2.4K in 2023 to EUR 4.9K in 2024 and EUR 7.5K in 2025. Short-term assets matched total assets in each reported year, indicating that the asset base was fully current. The 2025 asset turnover of 1.01x suggests that the organisation generated revenue broadly in line with its asset base. Overall, the financial profile for 2025 reflects a small but steadily growing membership organisation with improving scale and a rising asset position.